Follow Us:
Ketorolac

Toradol

Ketorolac

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe acute pain, including postoperative pain and certain musculoskeletal conditions. It works by inhibiting cyclooxygenase (COX) enzymes, reducing prostaglandin production and thereby relieving pain and inflammation.

Dosage Form: Tablet
Dosage Strength:
CAS No.: 74103-06-3
Status:
Manufacturer:
Group: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Sub Group: Non-selective COX inhibitors
Class: Pyrrolo-Pyrrole Derivatives

Uses of Ketorolac

Ketorolac was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

  • Acute moderate-to-severe pain: Short-term treatment of pain requiring stronger analgesia, including postoperative pain.
  • Postoperative pain: Management of pain following selected surgical procedures.
  • Musculoskeletal pain: Short-term relief of acute pain associated with injuries and inflammatory conditions.
  • Renal colic: Ketorolac may be used for acute pain associated with kidney stones.
  • Dental pain: Short-term relief of moderate-to-severe pain following selected dental procedures.
  • Ocular inflammation: Ophthalmic ketorolac preparations are used for postoperative eye pain and inflammation and certain allergic eye conditions, depending on the formulation.

Contraindication of Ketorolac

Ketorolac was historically subject to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Known hypersensitivity to ketorolac, aspirin, or other NSAIDs.
  • History of serious allergic reactions, including NSAID-induced asthma or anaphylaxis.
  • Active peptic ulcer disease or gastrointestinal bleeding.
  • History of gastrointestinal ulceration, bleeding, or perforation associated with NSAID treatment.
  • Moderate-to-severe renal impairment or risk of renal failure due to volume depletion.
  • Active bleeding or a high risk of bleeding.
  • Incomplete haemostasis or a high risk of postoperative bleeding.
  • Concurrent use with aspirin or other NSAIDs.
  • Use during labour and delivery.
  • Perioperative pain management associated with coronary artery bypass graft (CABG) surgery.

Precautions for Ketorolac

Ketorolac was majorly subjected to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Gastrointestinal complications: Ketorolac may cause stomach irritation, peptic ulcers, gastrointestinal bleeding, and, rarely, perforation.
  • Kidney function: Use cautiously in patients with impaired kidney function, dehydration, or conditions associated with reduced renal blood flow.
  • Bleeding risk: Ketorolac inhibits platelet function and may increase bleeding risk, particularly in patients undergoing surgery or taking anticoagulants.
  • Cardiovascular conditions: Use cautiously in patients with hypertension, heart disease, or fluid retention.
  • Asthma and hypersensitivity: Patients with aspirin-sensitive asthma or previous NSAID-related allergic reactions should avoid ketorolac unless specifically advised by a healthcare professional.
  • Elderly patients: Older adults may have a higher risk of gastrointestinal bleeding and kidney complications.
  • Pregnancy: Avoid routine use from 20 weeks of pregnancy unless specifically advised by a healthcare professional. Use from 30 weeks onward is generally avoided.
  • Treatment duration: Systemic ketorolac treatment should not exceed five days in adults because of the risk of serious adverse effects.
  • Concurrent NSAIDs: Avoid combining ketorolac with other NSAIDs because of increased toxicity.

Drug Interactions for Ketorolac

Potential drug interactions were historically documented when Ketorolac was prescribed alongside certain medications. These included:

  • Anticoagulants: Warfarin and direct oral anticoagulants may significantly increase the risk of bleeding.
  • Antiplatelet medicines: Aspirin and clopidogrel may increase bleeding risk when combined with ketorolac.
  • Corticosteroids: Prednisolone and other corticosteroids may increase the risk of gastrointestinal ulcers and bleeding.
  • Other NSAIDs: Ibuprofen, diclofenac, naproxen, and other NSAIDs should not be combined with ketorolac because of increased adverse-effect risks.
  • ACE inhibitors and ARBs: Concurrent use may increase the risk of kidney injury and reduce blood-pressure control.
  • Diuretics: Combination may reduce diuretic effectiveness and increase the risk of renal impairment.
  • Lithium: Ketorolac may increase lithium concentrations and the risk of toxicity.
  • Methotrexate: Concurrent use may reduce methotrexate clearance and increase toxicity.
  • Probenecid: May increase ketorolac concentrations and the risk of adverse effects.

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Ketorolac.

The Ketorolac is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Ketorolac.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Ketorolac, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Ketorolac Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Ketorolac

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Ketorolac Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Ketorolac, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Ketorolac

The export of Ketorolac from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Ketorolac Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Ketorolac specifications, certificates of analysis, and other supporting documents required for Ketorolac export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Ketorolac export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Ketorolac regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Ketorolac documentation, labelling, Ketorolac manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Ketorolac Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Ketorolac, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.